Document is current
Any future updates will be listed below
-
Authors
Nishimura, Rimei https://orcid.org/0000-0001-6222-119X
Okada, Yosuke
Kuroda, Akio
Suzuki, Junichi
Hirota, Yushi
Matsuhisa, Munehide
Ishiguro, Mizuki
Ohno, Takayuki
Suganuma, Yuka
Tanaka, Kenichi
Tone, Atsuhito
Yamamoto, Akane
Yoshida, Sumiko
,
- License Information
-
More Information
Article History
Received: 6 February 2025
Accepted: 9 May 2025
First Online: 18 June 2025
Declarations
:
: Rimei Nishimura: lecture fees (Sanofi K.K., Medtronic, Nippon Boehringer Ingelheim Co., Ltd., Teijin Pharma Ltd., Kissei Pharmaceutical Co., Ltd., Eli Lilly Japan K.K., Novo Nordisk Pharma Ltd., Astellas Pharma Inc., Abbott Japan, Sumitomo Pharma Co., Ltd., AstraZeneca, Kowa Co., Ltd., and Ono Pharmaceutical Co., Ltd.); research funds and grants (Mitsubishi Electric Corporation); endowments (scholarships) and donations (Taisho Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., Nippon Boehringer Ingelheim Co., Ltd., Abbott Japan, and Sumitomo Pharma Co., Ltd.). Yosuke Okada: lecture fees (MSD, Mitsubishi Tanabe Pharma Corporation, Novo Nordisk Pharma Ltd., Eli Lilly Japan K.K., Kowa Co., Ltd., and Sumitomo Pharma Co., Ltd.); research funds and grants (Kissei Pharmaceutical Co., Ltd.). Akio Kuroda: lecture fees (Eli Lilly Japan K.K.). Yushi Hirota: lecture fees (Novo Nordisk Pharma Ltd., Eli Lilly Japan K.K., Sanofi K.K., Terumo Corporation, Sumitomo Pharma Co., Ltd., and Abbott Japan); research funds and grants (Nippon Boehringer Ingelheim Co., Ltd., Sumitomo Pharma Co., Ltd., Kyowa Kirin Co., Ltd., and Medtronic); endowments (scholarships) and donations (Abbott Japan). Munehide Matsuhisa: lecture fees (Abbott Japan, Sanofi K.K., Sumitomo Pharma Co., Ltd., Eli Lilly Japan K.K., Novo Nordisk Pharma Ltd., Kyowa Kirin Co., Ltd., and Nippon Boehringer Ingelheim Co., Ltd.); research funds and grants (Japan Association for Diabetes Education and Care). Atsuhito Tone: lecture fees (Sanofi K.K., Eli Lilly Japan K.K., Abbott Japan, and Terumo Corporation).
